{
  "docId": "019de075-adb8-762c-8a34-68ae2626b554",
  "docSlug": "3a94cd37bbc178d56e25705cc2452800",
  "documentTitle": "Legend Biotech | Results Presentation Deck | 16 slides",
  "authorId": "legend-biotech",
  "authorName": "Legend Biotech",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-08-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 6,
  "pageCount": 16,
  "prevPage": 5,
  "nextPage": 7,
  "slideType": "comparison_table",
  "function": "analyze_data",
  "density": "balanced",
  "nDataPoints": 36,
  "notes": "The table compares clinical outcomes including ORR, CR, PFS, OS, DOR, and safety metrics like CRS, Neurotoxicity, and ICANS across different patient populations.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de075-adb8-762c-8a34-68ae2626b554/6",
  "deckHref": "/decks/019de075-adb8-762c-8a34-68ae2626b554",
  "deckJsonHref": "/decks/019de075-adb8-762c-8a34-68ae2626b554.json",
  "deckAnchorHref": "/decks/019de075-adb8-762c-8a34-68ae2626b554#slide-6",
  "components": [
    {
      "bbox": {
        "h": 0.135,
        "w": 0.925,
        "x": 0.065,
        "y": 0.845
      },
      "kind": "source-note",
      "text": "Footnotes explaining study details, abbreviations, and data sources.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "99cfb99e-0d28-49f4-bf7d-03ce7c3b39b1",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.635,
        "w": 0.814,
        "x": 0.093,
        "y": 0.198
      },
      "kind": "table",
      "text": "Comparison table of clinical metrics across LEGEND-2, CARTITUDE-1, and CARTITUDE-4 studies.",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "aaad8590-0aca-4d28-bfed-ed0a87e19898",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.056,
        "w": 0.794,
        "x": 0.103,
        "y": 0.103
      },
      "kind": "title",
      "text": "Updated Clinical Profile for Cilta-cel from ASCO 2023",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "585656d6-e71b-4988-a077-205d601970c3",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 7,
      "from": 6,
      "beatId": "dc206db6-781b-4463-87f2-42a43f50929a",
      "arcName": "The Sparkline",
      "arcSlug": "sparkline",
      "beatName": "Problem & Complication",
      "beatSlug": "consultants-gambit-problem-complication",
      "evidence": "The updated clinical profile for Cilta-cel and near-term label expansion potential are discussed, addressing challenges and progress.",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Complication",
      "parentBeatSlug": "complication"
    }
  ],
  "loops": [
    {
      "to": 7,
      "from": 6,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "33f76588-e3d7-4ba4-82dc-e0f8db9d19fe",
      "evidence": "The near-term label expansion potential for Cilta-cel is discussed, implying the cost of inaction.",
      "position": 0,
      "objective": "What are the consequences of not expanding Cilta-cel's label?",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}